HEMOPET (EIN 954063237) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

W JEAN DODDS

Phone

7148912022

Tax Period

2023-01-01 to 2023-12-31

HEMOPET, founded in 1986, is a community nonprofit in the Animal-Related sector that reported $3.9M in total revenue in fiscal year 2023. Revenue grew 11% year-over-year, indicating healthy expansion.

Mission

THE ORGANIZATION PROVIDES STATE OF THE ART BLOOD COMPONENTS AND SUPPLIES FOR VETERINARY CLINICS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $474,490

Program Service Revenue $3,350,410

Investment Income $64,581

Other Revenue $0

TOTAL REVENUE $3,889,481

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,445,760

Fundraising Expenses $0

Program Expenses $3,541,126

Other Expenses $2,773,126

TOTAL EXPENSES $4,218,886

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,889,481	$3,502,322	+0.1%
Expenses	$4,218,886	$3,978,719	+0.1%
Net Income	$-329,405	$-476,397	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
W JEAN DODDS DVM	PRESIDENT	50.00	Officer Director	$0	$0	$0
CHARLES BERMAN	SECRETARY,TREASURER,GENERA	10.00	Officer Director	$0	$0	$0
ERNIE SLOANE	DIRECTOR	0.00	Director	$0	$0	$0
RICHARD BAKER	DIRECTOR	0.00	Director	$0	$0	$0
MARK SUPONITSKY	DIRECTOR	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$3,889,481	$4,218,886	$465,901	$-329,405
2022	$3,502,322	$3,978,719	$683,573	$-476,397
2021	$3,989,667	$4,168,807	$419,478	$-179,140
2020	$4,172,725	$4,246,130	$526,067	$-73,405
2019	$3,937,992	$4,238,880	$618,548	$-300,888
2018	$4,590,075	$4,602,066	$467,480	$-11,991

HEMOPET